AmplifiDx: Faster and 10x cheaper than PCR. The next point-of-care molecular diagnostics platform.
Location: United States, California, Pleasanton
Employees: 11-50
Investors 3
| Date | Name | Website |
| 10.07.2021 | Life Scien... | lifescienc... |
| - | SeedFolio | seedfolio.... |
| - | K2X | k2x.capita... |
Mentions in press and media 1
| Date | Title | Description |
| 15.04.2026 | Shepherd Ventures III portfolio company AmplifiDX Secures Added Non-Dilutive Funding | Shepherd Ventures III NIH funds to AmplifiDX now total $5.7 million to develop technology to diagnose infections at the Point-of-Care and determine drug resistance quickly AmplifiDx is proud to combat drug-resistant infections by enabling r... |